DAX-0,21 % EUR/USD+0,19 % Gold+0,14 % Öl (Brent)+1,25 %

PROGENICS INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Progenics Pharmaceuticals, Inc. - PGNX

Nachrichtenquelle: Business Wire (engl.)
03.10.2019, 23:50  |  323   |   |   

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Progenics Pharmaceuticals, Inc. (NasdaqGS: PGNX) to Lantheus Holdings, Inc. (NasdaqGS: LNTH). Under the terms of the proposed transaction, shareholders of Progenics will receive only 0.2502 shares of Lantheus for each share of Progenics that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-pgnx/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Diesen Artikel teilen

Diskussion: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)...USD 6.56/24.8.2016
Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren



Meistgelesene Nachrichten des Autors


Diskussionen zu den Werten